Halle, Germany

Bianca Senns

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Imtm Gmbh. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bianca Senns. Retrieved from https://idiyas.com/inventor/bianca-senns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bianca Senns

Introduction

Bianca Senns is a notable inventor based in Halle, Germany. She has made significant strides in the field of medicinal chemistry, particularly in the development of therapeutic agents. Her work focuses on addressing inflammatory diseases through innovative approaches.

Latest Patents

Bianca Senns holds a patent for "Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases." This patent includes compounds of the general formulae (1) A-B-D-B'-A' and (2) A-B-D-E, which represent her innovative contributions to the field.

Career Highlights

Senns is currently associated with Imtm GmbH, where she continues to advance her research and development efforts. Her dedication to innovation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Bianca has collaborated with esteemed colleagues such as Siegfried Ansorge and Klaus Neubert. These partnerships have further enriched her research and contributed to her success.

Conclusion

Bianca Senns exemplifies the spirit of innovation in the realm of medicinal chemistry. Her contributions, particularly in the development of peptidase inhibitors, highlight her commitment to improving therapeutic options for inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…